✦ LIBER ✦

Oncolytic Viral Therapy of Malignant Glioma

✍ Scribed by Jacqueline Nuss Parker; David F. Bauer; James J. Cody; James M. Markert

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 114 KB
Volume: 6
Category: Article
ISSN: 1933-7213
DOI: 10.1016/j.nurt.2009.04.011

No coin nor oath required. For personal study only.

✦ Synopsis

Novel approaches to treatment of malignant glioma, the most frequently occurring primary brain tumor, have included the use of a wide range of oncolytic viral vectors. These vectors, either naturally tumor-selective, or engineered as such, have shown promise in the handful of phase I and phase II clinical trials conducted in recent years. The strategies developed for each of the different viruses currently being studied and the history of their development are summarized here. In addition, the results of clinical trials in patients and their implication for future trials are also discussed.

📜 SIMILAR VOLUMES

Oncolytic viral therapy for human cancer

Oncolytic viral therapy for human cancer: Challenges revisited

✍ Alex W. Tong 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

Molecular therapies for malignant glioma

✍ Markus Hutterer; Eberhard Gunsilius; Guenther Stockhammer 📂 Article 📅 2006 🏛 Springer Vienna 🌐 German ⚖ 396 KB

Molecularly targeted therapy for maligna

Molecularly targeted therapy for malignant glioma

✍ Sith Sathornsumetee; David A. Reardon; Annick Desjardins; Jennifer A. Quinn; Jam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 1 views

## Abstract Malignant gliomas are relatively uncommon but lethal cancers. Despite recent research efforts in cancer therapy, the prognosis of patients with malignant gliomas has remained dismal. Understanding the molecular pathogenesis of glioma may lead to a rational development of new therapies.

Trans-complementing adenoviral vectors f

Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma

✍ G. W. Wolkersdörfer; J. C. Morris; G. Ehninger; W. J. Ramsey 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB

## Abstract ## Background Despite attempts to develop efficient viral‐based gene transfer therapies for the treatment of malignant tumors, only limited progress has been made to improve the efficacy of this approach. As an alternative, the use of replicating oncolytic adenoviruses with and without

Antitumor efficacy of regional oncolytic

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer

✍ Joseph J. Bennett; David A. Kooby; Keith Delman; Priscilla McAuliffe; Marc W. Ha 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 146 KB

Effect of murine liver cell proliferatio

Effect of murine liver cell proliferation on herpes viral behavior: Implications for oncolytic viral therapy

✍ Keith A. Delman; Jonathan S. Zager; Amit Bhargava; Henrik Petrowsky; Sandeep Mal 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Replication-competent herpes simplex oncolytic viruses are promising anticancer agents that partly target increased DNA synthesis in tumor cells. Investigators have proposed that these DNA viruses may be combined with liver resection to enhance killing of liver malignancies. Whether or not the cellu